DNA Seq 2
DNA Seq 2 is a startup headquartered in Vista, United States, founded in 2022. It has raised at least $1.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
DNA Seq 2 has raised at least $1.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
DNA Seq 2 sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in Vista
Related
- Innovation profile of Vista
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does DNA Seq 2 do?
DNA Seq 2 is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has DNA Seq 2 raised?
At least $1.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is DNA Seq 2 based?
DNA Seq 2 is headquartered in Vista, United States.
When was DNA Seq 2 founded?
DNA Seq 2 was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.